Drugs / AX-024
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02243683 | Sep → Nov 2014 | — | Artax Biopharma Inc | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AX-024 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02243683 ↗ |
| Route | Oral | “Single ascending oral administrations of AX-024.HCl (hydrochloride) and matching placebo” NCT02243683 ↗ |